1,2-distearoylphosphatidylethanolamine has been researched along with perflubron in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berti, R; Chaminade, P; Chehimi, MM; Connan, C; Díaz-López, R; Fattal, E; Libong, D; Nicolas, V; Taulier, N; Tsapis, N; Urbach, W | 1 |
| Bridal, SL; Chaminade, P; Díaz-López, R; Fattal, E; Jaillard, D; Libong, D; Marsaud, V; Nicolas, V; Santin, M; Tsapis, N; Vauthier, C | 1 |
2 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and perflubron
| Article | Year |
|---|---|
Phospholipid decoration of microcapsules containing perfluorooctyl bromide used as ultrasound contrast agents.
Topics: Avidin; Biotinylation; Capsules; Contrast Media; Elements; Fluorescence; Fluorocarbons; Hydrocarbons, Brominated; Microscopy, Confocal; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Rhodamines; Spectrum Analysis; Streptavidin; Surface Properties; Ultrasonics | 2009 |
The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent.
Topics: Animals; Chromatography; Complement Activation; Complement C3; Contrast Media; Electrophoresis, Gel, Two-Dimensional; Fluorocarbons; Humans; Hydrocarbons, Brominated; Hydrophobic and Hydrophilic Interactions; Mice; Nanocapsules; Pancreatic Neoplasms; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Surface Properties; Ultrasonics; Ultrasonography | 2010 |